#Spain #Veeva Systems #Barcelona #UCB #Pharmacovigilance

UCB and Veeva Systems: A Strategic Safety Transformation

On June 9, 2026, in a significant move to enhance efficiency in its safety operations, UCB announced its partnership with Veeva Systems, aligning its global safety procedures with the Veeva Safety Suite. This integration is set to unify their global and local workflows, ensuring that all patient safety data is managed on a single platform, which will streamline the operations in a rapidly evolving regulatory landscape.

Enhancing Operational Efficiency

UCB is taking pivotal steps to standardize its pharmacovigilance processes, a critical component for any pharmaceutical organization committed to patient safety. The partnership with Veeva enables UCB to automate various processes like adverse event reporting. Jonas Maselis, UCB’s head of digital technology and patient safety, stated, “Using Veeva Safety Suite is a core step in UCB's safety transformation.” By moving to this singular platform, UCB aims to increase both oversight and the speed of case processing, simplifying submissions to health authorities.

The Benefits of Veeva Safety Suite

Veeva Safety Suite is designed for comprehensive end-to-end safety management. This platform features various tools:

• - Veeva Safety: Streamlines the intake and processing of adverse events.
• - Veeva SafetyDocs: Manages all necessary safety-related documentation and processes.
• - Veeva Safety Workbench: Provides advanced data analysis for efficient reporting.
• - Veeva Safety Signal: Facilitates the automation of signal detection, providing better insights and alignment across the organization.
• - Veeva Safety-RIM Connection: Automatically shares product information across various regulatory and safety operations to maintain clean data.

Through these advanced tools, UCB will cultivate a potent foundation for its pharmacovigilance functions, aimed at ensuring compliance and enhancing data quality.

Building a Culture of Safety

John Lawrie, Vice President at Veeva Safety, comments on UCB's ambitious goals, “By building a foundation powered by Veeva Safety Suite, UCB is enhancing global compliance while driving automation.” This commitment not only underlines UCB’s dedication to maintaining high safety standards but also reflects a growing trend within the pharmaceutical industry to invest in technology that promotes patient safety.

UCB’s decision to unify its global safety operations with Veeva's capabilities indicates a proactive approach to meet the challenges posed by increasing regulatory scrutiny and the necessity for faster, more efficient safety responses. The incorporation of such technology signals a modernization within UCB, harnessing automated features not just for operational efficiency, but ultimately for better patient outcomes.

Conclusion

The collaboration between UCB and Veeva Systems represents a pivotal evolution in the realm of pharmacovigilance. As these two entities come together, the focus remains clear—protecting patient safety through enhanced operational practices, fostering a culture of safety driven by innovation and compliance. Through these advancements, UCB is positioning itself not just to navigate current challenges but to lead within the pharmaceutical industry's safety landscape. This partnership serves as a benchmark for other organizations aiming to integrate technology within their safety operations effectively.

For more information on the integration of these systems and what it means for the future of pharmaceutical safety operations, stay tuned for further developments from UCB and Veeva Systems.